✦ LIBER ✦

Two grams daily of oral acyclovir reduces the incidence of cytomegalovirus disease in CMV-seropositive liver transplant recipients

✍ Scribed by J. Gavalda`, Jordi de Otero, Enric Murio, Victor Vargas…

Book ID: 120739038
Publisher: Springer
Year: 1997
Tongue: English
Weight: 138 KB
Volume: 10
Category: Article
ISSN: 0934-0874
DOI: 10.1007/s001470050087

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Two grams daily of oral acyclovir reduce

Two grams daily of oral acyclovir reduces the incidence of cytomegalovirus disease in CMV-seropositive liver transplant recipients

✍ J. Gavaldà; J. de Otero; A. Pahissa; E. Murio; C. Margarit; V. Vargas; J. Rossel 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 371 KB

Randomized controlled trial of oral ganc

Randomized controlled trial of oral ganciclovir versus intravenous ganciclovir for long-term prophylaxis of cytomegalovirus (CMV) disease in CMV-seronegative liver transplant recipients willi CMV-seropositive donors

✍ D. Winston; R.W. Busuttil 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 283 KB

High-dose acyclovir and intravenous immu

High-dose acyclovir and intravenous immune globulin reduce the incidence of CMV disease after liver transplantation

✍ Eytan Mor; Burt R. Meyers; Ozgur Yagmur; Keiji Kishikawa; Patricia A. Sheiner; S 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 473 KB

High-dose acyclovir and intravenous immu

High-dose acyclovir and intravenous immune globulin reduce the incidence of CMV disease after liver transplantation

✍ Eytan Mor; Burt R. Meyers; Ozgur Yagmur; Keiji Kishikawa; Patricia A. Sheiner; S 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 479 KB

Randomised trial of efficacy and safety

Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients

✍ Edward Gane; Faouzi Saliba; Garcia JC Valdecasas; John O'Grady; Mark D Pescovitz 📂 Article 📅 1997 🏛 The Lancet 🌐 English ⚖ 76 KB

Retrospective review of the incidence of

Retrospective review of the incidence of cytomegalovirus infection and disease after liver transplantation in pediatric patients: Comparison of prophylactic oral ganciclovir and oral valganciclovir

✍ Ashley N. Bedel; Trina S. Hemmelgarn; Rohit Kohli 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 747 KB

Cytomegalovirus (CMV) is the most common viral infection after solid organ transplantation (SOT). Safe and effective prophylactic regimens that decrease its incidence after SOT are essential for long-term graft survival. Although valganciclovir is not Food and Drug Administration-approved for CMV pr